OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors

FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors

Amazon earnings primer: Why AI and tariffs are key to the second quarter

We’re lowering our price target on Bristol Myers as two key overhangs persist

Stock Market Today: Indexes Trim Gains As Core Inflation Exceeds Views; Meta, Carvana Hit New Entries (Live)

Stock Market Today: Indexes Trim Gains As Core Inflation Exceeds Views; Meta, Carvana Hit New Entries (Live)

Roblox stock soars 16% after revenue beat, strong user growth

Microsoft ends tradition of naming competitors in regulatory filings

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

‘Dahmer’ becomes Netflix’s second-most watched series ever

October 12, 2022

Yahoo Finance entertainment reporter Allie Canal details the success of Netflix's TV series on serial killer Jeffrey Dahmer and the company's plans to build a...

3rdPartyFeeds

UPDATE 3-Google approves Trump’s Truth Social for Play Store

October 12, 2022

Alphabet Inc's Google has approved former U.S. President Donald Trump's social media app Truth Social for distribution in the Google Play Store, a company...

3rdPartyFeeds

Alphabet (GOOGL) Taps Coinbase to Add Crypto Payments to Cloud

October 12, 2022

Alphabet's (GOOGL) Google collaborates with Coinbase to allow users to pay for Google Cloud services using cryptocurrencies through the latter's crypto payment...

3rdPartyFeeds

Trump social-media SPAC jumps on report Google allows Truth Social

October 12, 2022

MARKET PULSE Shares of Digital World Acquisition Corp., (DWAC) the special-purpose acquisition company planning to take former President Donald Trump’s media...

3rdPartyFeeds

Amazon Shoppers Favor Household Goods Over Big-Ticket Items in Second Prime Day

October 12, 2022

(Bloomberg) -- Amazon.com Inc. shoppers are largely skipping pricey purchases during the company’s Prime sale sequel -- favoring pantry items and affordable...

3rdPartyFeeds

Why Canopy Growth and Tilray Blasted Higher Today

October 12, 2022

More than a few handily beat the market, with bellwethers Canopy Growth (NASDAQ: CGC) and Tilray (NASDAQ: TLRY) closing a respective 4.2% and 6.2% higher...

3rdPartyFeeds • News

Market Extra: Why questions are swirling about who will buy most of the U.S.’s $31 trillion in debt — and at what price

October 12, 2022

U.S. national debt is above $31 trillion for the first time as the Federal Reserve is in retreat from buying it and foreign investors' interest is waning. Read...

3rdPartyFeeds

Squarespace, a Website-Development Firm, Names Amazon Executive as CFO

October 12, 2022

Nathan Gooden is set to succeed Marcela Martin, who left for BuzzFeed this summer. He is the latest in a string of Amazon executives to take over the finances...

3rdPartyFeeds

Microsoft Teams up With Apple (This Might Just Be the Start)

October 12, 2022

This conflict most often occurs between two major makers of laptop and desktop computers, tablets, and mobile devices: Apple and Microsoft . Apple's Mac...

3rdPartyFeeds

Why Shares of PayPal Are Rising Today

October 12, 2022

Shares of the large payments firm PayPal (NASDAQ: PYPL) traded about 1.15% higher as of 3 p.m. ET after a Wall Street analyst said he thinks the stock has been...

Previous 1 … 2,133 2,134 2,135 2,136 2,137 … 8,320 Next
Indices by TradingView
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors

FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors

July 31, 2025

Amazon earnings primer: Why AI and tariffs are key to the second quarter

July 31, 2025

We’re lowering our price target on Bristol Myers as two key overhangs persist

July 31, 2025
Stock Market Today: Indexes Trim Gains As Core Inflation Exceeds Views; Meta, Carvana Hit New Entries (Live)

Stock Market Today: Indexes Trim Gains As Core Inflation Exceeds Views; Meta, Carvana Hit New Entries (Live)

July 31, 2025

Roblox stock soars 16% after revenue beat, strong user growth

July 31, 2025

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.